Endotoxin-induced HIF-1α stabilisation in equine endothelial cells: synergistic action with hypoxia
Objective and design Hypoxia may enhance the deleterious effects of lipopolysaccharide (LPS) in the endotoxaemic horse. This study has examined some of the actions of LPS and hypoxia, alone and in combination, on cultured equine digital vein endothelial cells (EDVEC) and the signalling molecules inv...
Gespeichert in:
Veröffentlicht in: | Inflammation research 2010-09, Vol.59 (9), p.689-698 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective and design Hypoxia may enhance the deleterious effects of lipopolysaccharide (LPS) in the endotoxaemic horse. This study has examined some of the actions of LPS and hypoxia, alone and in combination, on cultured equine digital vein endothelial cells (EDVEC) and the signalling molecules involved. Methods EDVEC were exposed to LPS, 5% O₂ and LPS then 5% O₂ for up to 24 h. HIF-1α stabilisation, neutrophil adhesion and EDVEC permeability were assessed by immunoblotting, measurement of myeloperoxidase and movement of FITC-dextran, respectively. Pharmacological inhibitors were used to assess the roles of p38 MAPK and HIF-1α. Results LPS and hypoxia significantly increased HIF-1α stabilisation, neutrophil adhesion and EDVEC permeability and the effects of the two stimuli in combination on HIF-1α stabilisation and neutrophil adhesion were more than additive. The effect of LPS, but not 5% O₂, on neutrophil adherence required activation of p38 MAPK, whereas EDVEC permeability in response to both stimuli was dependent on p38 MAPK and HIF-1α. Conclusions Exposure of EDVEC to LPS prior to induction of hypoxia up-regulates responses that may enhance LPS-induced tissue damage in the endotoxaemic horse. Inhibitors of p38 MAPK or HIF-1α could reduce such unwanted effects. |
---|---|
ISSN: | 1023-3830 1420-908X |
DOI: | 10.1007/s00011-010-0180-x |